Wolverine Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,853
Closed -$119K 2251
2021
Q1
$119K Sell
1,853
-459
-20% -$29.6K ﹤0.01% 1396
2020
Q4
$134K Sell
2,312
-3,593
-61% -$217K ﹤0.01% 1152
2020
Q3
$373K Buy
+5,905
New +$409K ﹤0.01% 808
2020
Q1
Sell
-19
Closed -$1K 1524
2019
Q4
$1K Hold
19
﹤0.01% 1332
2019
Q3
$1K Hold
19
﹤0.01% 1363
2019
Q2
$1K Hold
19
﹤0.01% 1364
2019
Q1
$1K Hold
19
﹤0.01% 1321
2018
Q4
$1K Sell
19
-335
-95% -$23.4K ﹤0.01% 1578
2018
Q3
$27K Sell
354
-416
-54% -$31.4K ﹤0.01% 1390
2018
Q2
$54K Hold
770
﹤0.01% 1234
2018
Q1
$58K Sell
770
-111,659
-99% -$8.88M ﹤0.01% 1280
2017
Q4
$8.05M Buy
+112,429
New +$8.54M 0.08% 210
2017
Q3
Sell
-4,300
Closed -$329K 1399
2017
Q2
$304K Buy
+4,300
New +$286K ﹤0.01% 883
2016
Q3
Sell
-1,950
Closed -$158K 1257
2016
Q2
$162K Buy
1,950
+1,750
+875% +$155K ﹤0.01% 907
2016
Q1
$18K Sell
200
-4,500
-96% -$406K ﹤0.01% 1004
2015
Q4
$475K Sell
4,700
-500
-10% -$52K 0.01% 664
2015
Q3
$510K Buy
5,200
+4,600
+767% +$511K 0.01% 666
2015
Q2
$70K Buy
+600
New +$65.6K ﹤0.01% 1213
2015
Q1
Sell
-71,580
Closed -$7.27M 1961
2014
Q4
$6.75M Sell
71,580
-7,491
-9% -$775K 0.13% 141
2014
Q3
$8.42M Sell
79,071
-15,678
-17% -$1.54M 0.18% 112
2014
Q2
$7.86M Buy
94,749
+5,453
+6% +$424K 0.17% 108
2014
Q1
$6.33M Buy
89,296
+32,800
+58% +$2.57M 0.14% 138
2013
Q4
$4.24M Buy
56,496
+34,646
+159% +$2.41M 0.08% 193
2013
Q3
$1.37M Sell
21,850
-17,150
-44% -$1.02M 0.03% 440
2013
Q2
$2M Buy
+39,000
New +$2.03M 0.05% 301

Other funds holding GILD

Wolverine Asset Management's GILD Position: Q2 2021 in Review

Wolverine Asset Management sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 1,853 shares — an estimated $119K sold.

Wolverine Asset Management first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $8.42M in Q3 2014. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Wolverine Asset Management reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Wolverine Asset Management sold 1,853 Gilead Sciences shares in Q2 2021, an estimated $119K.
  • Wolverine Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
  • Wolverine Asset Management's Gilead Sciences position peaked at $8.42M in Q3 2014.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.